Catalysts
PRODUCTS
-
Immunotherapy is an evolving and promising cancer treatment that works by stimulating the immune system. More biologically relevant human primary cells are now the chosen starting material for immunotherapy development. Historically, scientists routinely used immortalized cell lines in the research and development of therapies as they offer an inexpensive and stable platform. However, they are not fully representative of what is going on in vivo.
-
MassFerence P2 calibrant for the SamuxMP and SamuxMP Auto
Ref: MP-CON-41015
-
The XG Series low-profile gap capacitor features low insertion loss and ultra high self resonance frequencies for applications including DC blocking, RF Bypass, impedance matching, filtering, tuning and coupling.
-
Mycenax’s state-of-the-art biomanufacturing site is PIC/S GMP certified. Our highly qualified and well-trained team routinely manufactures high-quality biopharmaceutical products by mammalian cell culture and microbial fermentation processes. We continuously invest in our technologies and infrastructure to ensure that we constantly meet your evolving needs of today and tomorrow.
-
The PTXM9754 is an ultra compact modular microwave power module (MPM) with an integrated “super mini” travelling wave tube (TWT), a solid state preamplifier and an optimised high density switch mode power supply.
WHITE PAPERS AND CASE STUDIES
-
Leveraging High-Pressure Sterile Filtration For Highly Viscous Solutions
This research demonstrates the potential of high-pressure sterile filtration to enhance efficiency, reduce waste, and accelerate the development of innovative therapies.
-
Enhancing Water Quality For Mountaire Farms
Mountaire Farms resolved their wastewater facility issues by replacing mechanical surface aerators with SDOX technology, saving $38 million and improving treatment.
-
Resolving Odor Complaints With Targeted Solutions Restore Community Confidence
The South Dearborn Regional Sewer District in Lawrenceburg, Indiana, provides regional wastewater treatment services for three cities and an international distillery. The 6 mgd treatment plant is located in an area of high population growth and is surrounded by many retail operations and other commercial developments. In addition, a heavily traveled state highway runs by the treatment plant.
-
Supporting Participants Through National Travel Disruptions
A sudden travel shutdown threatened a critical clinical visit. Rapid rescheduling, coordinated logistics, and clear communication ensured engagement and the ability to continue without interruption.
-
Reducing The Burden Of Patient Retention And Improving Continuity
Immunology trials often place a sustained burden on participants. However, integrating Home Trial Support (HTS) into a Phase 3 immunology trial can help improve the overall study experience.
-
Changing The Clinical Feasibility Game With AI
AI is only as good as the data it’s built upon. Our customized AI platforms are constructed on a foundation of trustworthy, carefully curated data to produce detailed, expert-driven responses.
-
Data Key In Addressing Patient Recruitment Challenges
Explore how a Phase II trial for extensive-stage and previously treated small cell lung cancer overcame recruitment challenges with a data-driven solution designed to surface protocol-matched patients.
-
RO Membrane Protection For A Desalination Plant In Mejillones, Chile
Read about a seawater desalination plant that presented with several performance issues and chose the HOD UV system to control biofouling on the RO membranes.
-
De-Risking Automatic Visual Inspection (AVI) Through Integrated Validation
Aligning visual inspection systems with site standards prevents costly validation failures. Discover strategies to de-risk equipment startup.
-
Multiple Fill Line Delivery Experience
Learn how a multinational pharmaceutical company successfully implemented a global strategy for insulin cartridge filling, achieving seamless regulatory approval with zero deviations.
-
Ergomed's Solutions To The Challenges of Oncology Trials
Explore a pivotal Phase III global clinical trial investigating neoadjuvant immunotherapy for locally advanced squamous cell carcinoma of the head and neck (LA SCCHN).
-
Automated Trial Monitoring Workflows Make A Lean Team More Efficient
A pharmaceutical therapy developer was looking to automate reports, confirmation letters, and follow-up letters. See what happened when they adopted a cloud-based solution for end-to-end trial management.
NEWS
-
Kontron Introduces The New AL I.MX8M Mini LTE: IoT Gateway With LTE Cat1 Module5/6/2025
Kontron, a leading global supplier of IoT/Embedded Computer Technology (ECT), is expanding its automation line with the AL i.MX8M Mini LTE model.
-
Xscape Photonics And Tower Semiconductor Unveil The Industry's First Optically Pumped On-Chip Multi-Wavelength Laser Platform For AI Datacenter Fabrics8/25/2025
Tower Semiconductor (NASDAQ/TASE: TSEM), a leading foundry of high-value analog semiconductor solutions, and Xscape Photonics, a U.S.-based innovator in advanced photonic interconnects funded by industry leaders such as NVIDIA and Cisco, today announced the successful prototyping and validation kit availability of the industry’s first on-chip, optically pumped, multi-wavelength laser source
-
Spearhead Bio Awarded NSF Tech Transfer Grant To Accelerate Development Of Improved Corn Varieties7/14/2025
Spearhead Bio, a biotechnology startup revolutionizing crop genome engineering through the use of plants' own natural DNA, has been awarded a Small Business Technology Transfer (STTR) Phase I grant from the U.S. National Science Foundation (NSF).
-
Trident IoT Unveils Revolutionary Software Development Kits For Z-Wave/ZWLR And Zigbee RF SoCs4/2/2025
Trident IoT is proud to announce the release of its highly anticipated Software Development Kits (SDKs) for its latest line of Z-Wave/ZWLR and Zigbee RF System-on-Chips (SoCs).
-
STMicroelectronics Announces Mass Production And Lead Customer Success For Turnkey Bluetooth/Wi-Fi Modules Developed With Qualcomm6/4/2025
STMicroelectronics has announced mass-production start for its ST67W611M1 combined Wi-Fi 6 and Bluetooth Low Energy 5.4 module, describing the early success of Siana, a lead customer for its fast-to-market connectivity.
ABOUT
Catalysts
Catalysts work by changing the structure of a molecule or by bonding to reactant molecules causing them to combine, react, and release a product or energy. For example, a catalyst is required in order for oxygen and hydrogen to bond, combine and produce water.
Catalysts increase the rate of chemical reactions. Unlike a reagent that gets consumed as apart of the chemical reaction, catalysts do not get consumed in the reaction. They can actually participate in multiple chemical transformations.Catalysts can be organic, synthetic or metal.
All processes need energy to take place. Processes require a very high level of energy in order to spark or start if a catalyst isn’t present. When a catalyst is present the amount of energy required to spark the reaction is lowered and that makes the reaction happen faster and more efficiently.
Catalytic effects vary depending on other substances present that are a part of the chemical reactions. There are certain substances that can inhibit the effectiveness of a catalyst like poisons, and other substances that promote or increase the effect of the catalyst. Inhibitors or negative catalysts are very important in medicine to treat mental illnesses, high blood pressure, cancer and many other diseases.
Catalysts are often used to help crack, or split, larger organic molecules like hydrocarbons into simpler molecules. It does this by breaking carbon-carbon bonds. The speed of the splitting process depends heavily on what specific catalyst is used and the temperature. Applications of this technology include oil and petrochemical industries.